Targeted Electromagnetic Stimulation for Non-Neurological Applications
Legal Citation
Summary of the Inventive Concept
A novel approach applying the core technology of targeted neuromodulation to various non-neurological fields, including agriculture, veterinary medicine, and athletic performance, to enhance growth, treat diseases, and improve cognitive abilities.
Background and Problem Solved
The original patent focused on neuromodulation therapy for treating mental conditions in humans. However, the core technology has the potential to be applied to other industries and fields. The new inventive concept addresses the limitations of the original patent by expanding its application to non-neurological domains, where targeted electromagnetic stimulation can have a significant impact.
Detailed Description of the Inventive Concept
The new inventive concept utilizes the same processor and memory containing a targeting application as the original patent, but adapts it to obtain crop data, animal brain data, or athletic performance data. The application then directs the processor to apply electromagnetic stimulation to specific regions of the crop, animal brain, or athlete's brain to achieve the desired outcome. This includes enhancing growth and yield in crops, treating plant diseases, enhancing cognitive abilities in animals, improving athletic performance, and treating neurological disorders in veterinary medicine.
Novelty and Inventive Step
The new claims introduce a non-obvious and novel application of the core technology to non-neurological fields, which is distinct from the original patent's focus on neuromodulation therapy for mental conditions in humans.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of electromagnetic stimulation, such as transcranial magnetic stimulation or transcranial direct current stimulation, or integrating the technology with other systems, like precision agriculture or wearable devices. Variations may also involve adapting the technology for use in different species or applications, such as treating diseases in livestock or enhancing cognitive abilities in companion animals.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in various industries, including agriculture, veterinary medicine, and sports technology. The target market includes companies and organizations focused on precision agriculture, animal health, and human performance enhancement, as well as research institutions and universities exploring new applications of electromagnetic stimulation.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B34/20 |
| A | A61 | A61B5/0036 |
| A | A61 | A61B5/055 |
| A | A61 | A61N1/20 |
| A | A61 | A61N1/36096 |
| A | A61 | A61N2/006 |
| G | G01 | G01R33/4806 |
| G | G01 | G01R33/5608 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering and neuromodulation technologies, with expertise in brain stimulation techniques, medical imaging, and targeted electromagnetic interventions across biological systems
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biomedical engineering, neuroscience, or related fields, possessing knowledge of electromagnetic stimulation techniques, brain mapping technologies, and interdisciplinary applications of neurological intervention strategies
Obviousness Rationale
A PHOSITA would recognize that the core technological framework of targeted electromagnetic stimulation disclosed in the source patent represents a generalizable approach that can be systematically adapted across biological systems. The fundamental technical elements - processor-driven targeting, electromagnetic stimulation, and region-specific intervention - are directly transferable to multiple domains beyond human neurological treatment. The PTD demonstrates predictable extensions of the original technological concept by maintaining the core computational and stimulation methodologies while simply substituting different biological targets.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,275 |
|---|---|
| Title | Systems and methods for targeted neuromodulation |
| Assignee(s) | The Board of Trustees of the Leland Stanford Junior University |